Safety seems to be alright, no comments on early signals. But that would be too early I guess, especially when just 3 out of planned 20 patients have been dosed with the lowest dose.
And the strange situation continues, CHM is the most advanced CAR-T company listed on the ASX having actually clinical CAR-T trials running and valued ZERO. The other one is IMU and despite cell therapy and CAR-T are the hottest oncology topics in the US with rising valuations of those comps the 2 ones here are getting smashed. The even more strange thing is that those ASX stocks still at pre-clinical are valued 10-15 more than CHM.
3 CAR-Ts, GBM and the above mentioned AML are already poised to be " promoted " to move to rego trials soon and CDH17, the first direct CAR-T taking on solid cancers. And yet, neither the chair nor CHM itself can't find an investor.
Strange indeed or are in-house made mistakes to blame? The science doesn't lie, a screaming buy. From here either total loss or the biggest windfall ever.
Will or can the chair, once called the one with the MIDAS-Touch, turn the fortunes around or will he deliberately drive this gem into the deepest financial ground?
GLTA
- Forums
- ASX - By Stock
- CHM
- Ann: Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA
Ann: Phase 1b ADVENT-AML trial of CHM CORE-NK advances at MDA, page-4
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CHM (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.29M |
Open | High | Low | Value | Volume |
1.6¢ | 1.6¢ | 1.6¢ | $5.12K | 320K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 973796 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.7¢ | 617827 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 973796 | 0.015 |
8 | 1132261 | 0.014 |
4 | 1266666 | 0.013 |
4 | 283515 | 0.012 |
2 | 204041 | 0.011 |
Price($) | Vol. | No. |
---|---|---|
0.017 | 617827 | 2 |
0.018 | 200000 | 3 |
0.019 | 1948702 | 6 |
0.020 | 1123093 | 4 |
0.021 | 140000 | 1 |
Last trade - 14.43pm 13/09/2024 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online